Page last updated: 2024-09-02

cgp 39551 and oxadiazoles

cgp 39551 has been researched along with oxadiazoles in 1 studies

Compound Research Comparison

Studies (cgp 39551)	Trials (cgp 39551)	Recent Studies (post-2010) (cgp 39551)	Studies (oxadiazoles)	Trials (oxadiazoles)	Recent Studies (post-2010) (oxadiazoles)
75	0	4	6,057	257	2,359

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brugger, F; Fagg, GE; Olpe, HR; Pozza, MF	1

Other Studies

1 other study(ies) available for cgp 39551 and oxadiazoles

Article	Year
Electrophysiological characterization of a novel potent and orally active NMDA receptor antagonist: CGP 37849 and its ethylester CGP 39551. European journal of pharmacology, 1990, Jun-21, Volume: 182, Issue:1 Topics: 2-Amino-5-phosphonovalerate; Animals; Behavior, Animal; Electrophysiology; Hippocampus; Iontophoresis; Male; Oxadiazoles; Piperazines; Quisqualic Acid; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter; Spinal Cord; Substantia Nigra; Valine	1990

Article

Year

Electrophysiological characterization of a novel potent and orally active NMDA receptor antagonist: CGP 37849 and its ethylester CGP 39551.

European journal of pharmacology, 1990, Jun-21, Volume: 182, Issue:1

Topics: 2-Amino-5-phosphonovalerate; Animals; Behavior, Animal; Electrophysiology; Hippocampus; Iontophoresis; Male; Oxadiazoles; Piperazines; Quisqualic Acid; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter; Spinal Cord; Substantia Nigra; Valine

1990